Rituximab therapy achieves comparable remission to cyclophosphamide in ANCA-associated vasculitis with severe kidney involvement.

Chaudhari N, Ul Hussain A, Quill L, Harridine J, Eqbal K, Harper L, Chanouzas D

Open source

DOI
10.1093/ckj/sfag290
Published
2026 Sep
Container
Clinical kidney journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ckj/sfag290,
  title = {Rituximab therapy achieves comparable remission to cyclophosphamide in ANCA-associated vasculitis with severe kidney involvement.},
  author = {Chaudhari N and Ul Hussain A and Quill L and Harridine J and Eqbal K and Harper L and Chanouzas D},
  year = {2026},
  journal = {Clinical kidney journal},
  doi = {10.1093/ckj/sfag290},
  url = {https://doi.org/10.1093/ckj/sfag290}
}

RIS

TY  - JOUR
TI  - Rituximab therapy achieves comparable remission to cyclophosphamide in ANCA-associated vasculitis with severe kidney involvement.
AU  - Chaudhari N
AU  - Ul Hussain A
AU  - Quill L
AU  - Harridine J
AU  - Eqbal K
AU  - Harper L
AU  - Chanouzas D
PY  - 2026
JO  - Clinical kidney journal
DO  - 10.1093/ckj/sfag290
UR  - https://doi.org/10.1093/ckj/sfag290
ER  - 

APA

N, C., A, U. H., L, Q., J, H., K, E., L, H., & D, C. (2026). Rituximab therapy achieves comparable remission to cyclophosphamide in ANCA-associated vasculitis with severe kidney involvement.. Clinical kidney journal. https://doi.org/10.1093/ckj/sfag290

Source records